This inventor holds 1 USPTO granted patent. Top assignee: Westfaelische Wilhelms-Universitaet Muenster. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Stefani Silke Schilson: Innovator in S1P Receptor Research
Introduction
Stefani Silke Schilson is a prominent inventor based in Muenster, Germany. She has made significant contributions to the field of biomedical research, particularly in the area of S1P receptors. Her innovative work focuses on the development of novel compounds that have the potential to improve the diagnosis and treatment of various diseases.
Latest Patents
Stefani holds a patent for "Ligands for targeting of S1P receptors for in vivo imaging and treatment of diseases." This invention relates to novel compounds of formulae (I) and (II) that are useful in the prevention, treatment, and diagnosis of diseases associated with S1P receptors. These diseases include inflammation, pain, autoimmune disorders, and cardiovascular diseases. She has been granted 1 patent for her groundbreaking work.
Career Highlights
Stefani is affiliated with the Westfälische Wilhelms-Universität Münster, where she conducts her research. Her academic background and expertise have positioned her as a leader in her field. She is dedicated to advancing the understanding of S1P receptors and their role in various health conditions.
Collaborations
Stefani has collaborated with notable colleagues, including Guenter Haufe and Bodo Levkau. These partnerships have enhanced her research efforts and contributed to the development of innovative solutions in her area of expertise.
Conclusion
Stefani Silke Schilson is a trailblazer in the field of S1P receptor research, with a focus on developing novel compounds for medical applications. Her contributions are paving the way for advancements in the treatment and diagnosis of critical health issues.